Q1

SK Capital Makes Strategic Investment in Spectrum Vascular

Spectrum Vascular (“Spectrum” or the “Company”), a provider of vascular access and medication management products designed to reduce health care-acquired infections, announces a strategic investment by an affiliate of New York-based private investment firm SK Capital Partners (“SK Capital”). SK Capital, which manages a growing portfolio of companies focused on the specialty materials, ingredients, and […]

SK Capital Makes Strategic Investment in Spectrum Vascular Read More »

Topcon to Accelerate Growth through Management Buyout with KKR and JIC Capital

Topcon Corporation (“Topcon” or the “Company”; TSE stock code 7732) announces that it is launching a management buyout (“MBO”) led by Topcon President and CEO Takashi Eto. The MBO will receive investment from funds managed by KKR, a leading global investment firm, and JIC Capital (“JICC”), a wholly owned subsidiary of Japan Investment Corporation (“JIC”).

Topcon to Accelerate Growth through Management Buyout with KKR and JIC Capital Read More »

Eargo and hearX Close Merger, Announce New Combined Company, LXE Hearing

Hearing health pioneers Eargo and hearX, maker of Lexie hearing aids, announce that they have completed their merger, resulting in the creation of a combined company called LXE Hearing. Backed by an additional $100 million investment from Patient Square Capital, the deal creates a new hearing health company and is the first notable combination for

Eargo and hearX Close Merger, Announce New Combined Company, LXE Hearing Read More »

Cotiviti Completes Acquisition of Edifecs

Cotiviti, a leader in data-driven healthcare solutions, has completed its acquisition of Edifecs, a pioneer in healthcare data interoperability. Furthering Cotiviti’s vision to enable a high-quality and viable healthcare system, the acquisition will expand and accelerate the development of innovative healthcare technologies to drive advancement in data analytics, interoperability, and value-based care solutions that ultimately

Cotiviti Completes Acquisition of Edifecs Read More »

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical

HOPE Therapeutics, Inc., (“HOPE,” the “Company”), an interventional psychiatry network wholly owned by NRx Pharmaceuticals, Inc. (“NRx”) (Nasdaq: NRXP), announces signing of a definitive Agreement to acquire Dura Medical (Dura), per the previously announced non-binding Letter of Intent. Dura, together with the previously announced Neurospa network, are anticipated to provide a comprehensive service offering to

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical Read More »

Scroll to Top